Canadian Solar Inc. Announces Results of 2025 Annual Meeting of Shareholders

Canadian Solar Inc. Announces Results of 2025 Annual Meeting of Shareholders

KITCHENER, ON, June 20, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that it held its Annual Meeting of Shareholders on June 20, 2025. Each of the proposals submitted for shareholder...

Tuya Inc. Announces Results of Annual General Meeting

Tuya Inc. Announces Results of Annual General Meeting

SANTA CLARA, Calif., June 19, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced the results of its annual general meeting (the "Annual General...

111, Inc. Announces First Quarter 2025 Unaudited Financial Results

111, Inc. Announces First Quarter 2025 Unaudited Financial Results

Maintained Quarterly Operational Profitability Operating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoY Maintained Quarterly Positive Operating Cash Flow SHANGHAI, June 19, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company")...

Noah Holdings Limited Announces Results of Annual General Meeting and Payment of Final Dividend and Special Dividend

Noah Holdings Limited Announces Results of Annual General Meeting and Payment of Final Dividend and Special Dividend

SHANGHAI, June 12, 2025 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and...

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

CHENGDU, China, June 7, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating sacituzumab tirumotecan (sac-TMT)...

Over USD 900 million mobilized to accelerate the clean energy transition at the 2025 SEforALL Global Forum

Over USD 900 million mobilized to accelerate the clean energy transition at the 2025 SEforALL Global Forum

BRIDGETOWN, Barbados, March 17, 2025 /PRNewswire/ -- The SEforALL Global Forum has witnessed groundbreaking commitments totalling over USD 900 million to scale energy access and drive the clean energy transition. Moreover, key global partners...

menu
menu